0001127602-23-019766.txt : 20230705 0001127602-23-019766.hdr.sgml : 20230705 20230705081133 ACCESSION NUMBER: 0001127602-23-019766 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Stan CENTRAL INDEX KEY: 0001913199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41455 FILM NUMBER: 231066710 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAIA Biotechnology, Inc. CENTRAL INDEX KEY: 0001878313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-416-8592 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2023-06-30 0001878313 MAIA Biotechnology, Inc. MAIA 0001913199 Smith Stan 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 1 0 Stock Options 2.20 2023-06-30 4 A 0 11138 0 A 2023-06-30 2033-06-30 Common Stock 11138 11138 I See Footnote The stock options, granted on June 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993. /s/ Stan V. Smith 2023-07-05